Search results
GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology
Reuters via Yahoo Finance· 1 day ago(Reuters) -GlaxoSmithKline sued Pfizer and BioNTech in Delaware federal court on Thursday, accusing...
COVID-19 vaccines: CDC says people ages 65 and up should get a shot this spring – a geriatrician...
The Conversation via Yahoo News· 1 month agoEven if you got a COVID-19 shot last fall, the spring shot is still essential for the 65 and up age...
Largest multicountry COVID study links vaccines to potential adverse effects
The Hill via Yahoo News· 2 months agoA new study on COVID-19 vaccines that looked at nearly 100 million vaccinated individuals affirmed...
GlaxoSmithKline Clocks 32% Topline Growth Buoyed By COVID-19 Therapy, Shingrix Vaccine
Benzinga via Yahoo Finance· 2 years agoView more earnings on GSKSee more from BenzingaThe Daily Biotech Pulse: Molecular Partners Plunges...
Why GSK May Have Bet Too Big on a Pandemic Pipeline
Motley Fool· 2 years agoPharmaceutical giant GlaxoSmithKline (NYSE: GSK) missed out on this early action and now looks to launch several pandemic products this year. GSK has...
Why It Took So Long to Finally Get an RSV Vaccine
Time via Yahoo News· 12 months agoCredit - Getty Images; GSK Respiratory syncytial virus (RSV) can dangerously compromise breathing, especially for infants and the elderly. But there has...
Shingles Vaccine Market is Booming in Near Future 2023-2031
NewMediaWire via Yahoo Finance· 1 year agoPune, India - (NewMediaWire) - March 3, 2023 - "Shingles Vaccine" Size, Scope, and Forecast...
FTSE 100: GSK tops forecasts after strong sales of shingles vaccine
Yahoo Finance UK· 1 year agoGSK (GlaxoSmithKline) logo is seen in this illustration, August 10, 2022. REUTERS/Dado...
COVID vaccine makers shift focus to boosters
Reuters via AOL· 2 years agoCOVID-19 vaccine makers are shifting gears and planning for a smaller, more competitive booster shot market after delivering as many doses as fast as...
2 Dividend Stocks to Double Up On Right Now
Motley Fool· 2 years agoAbbVie (NYSE: ABBV) and GlaxoSmithKline (NYSE: GSK) have much in common. They are huge pharmaceutical companies that have a long record of success,...